• 검색 결과가 없습니다.

Overexpression of EFGR as Prognostic Factor and Effect of EGF in the Progression of Hypopharyngeal Cancer

N/A
N/A
Protected

Academic year: 2021

Share "Overexpression of EFGR as Prognostic Factor and Effect of EGF in the Progression of Hypopharyngeal Cancer"

Copied!
10
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

-  - 대한 두경부 종양 학회지

제  권 제  호 

Overexpression of EFGR as Prognostic Factor and Effect of EGF in the Progression of Hypopharyngeal Cancer

Young Chang Lim, MD

1

, Eun Chang Choi, MD, PhD

2

, Yoon Tae Kim, MD

3,4

, Jang Hee Kim, MD, PhD

5

, Hye Sook Hwang

3,4

, Sung Un Kang, PhD

3,4

, Jae Won Chang, MD

3,4

, Yoo Seob Shin, MD

3,4

, Chul-Ho Kim, MD, PhD

3,4

'HSDUWPHQWRI2WRUKLQRODU\QJRORJ\+HDGDQG1HFN6XUJHU\



5HVHDUFK,QVWLWXWHRI0HGLFDO6FLHQFH

.RQNXN8QLYHUVLW\6FKRRORI0HGLFLQH6HRXO.RUHD

'HSDUWPHQWRI2WRUKLQRODU\QJRORJ\



&ROOHJHRI0HGLFLQH<RQVHL8QLYHUVLW\6HRXO.RUHD

'HSDUWPHQWRI2WRODU\QJRORJ\



DQG&HQWHUIRU&HOO'HDWK5HJXODWLQJ%LRGUXJV



6FKRRORI0HGLFLQH$MRX8QLYHUVLW\

6XZRQ.RUHD

'HSDUWPHQWRI3DWKRORJ\



6FKRRORI0HGLFLQH$MRX8QLYHUVLW\6XZRQ.RUHD

하인두암에서 예후인자로서의 표피성장인자수용체(EGFR) 과발현과 하인두암의 진행에 있어 표피성장인자(EGF)의 역할 분석

건국대학교 의과대학 이비인후-두경부외과학교실,1 연세대학교 의과대학 이비인후과학교실,2

아주대학교 의과대학 이비인후과학교실,3 세포사멸조절연구센터,4 아주대학교 의과대학 병리과학교실5

임영창1・최은창2・김윤태3,4・김장희5・황혜숙3,4・강성운3,4・장재원3,4・신유섭3,4・김철호3,4

= 국 문 초 록 =

연구배경 및 목적

표피성장인자수용체(EGFR)는 HER2/neu(erbB2), HER3(erbB3), HER4(erbB4)를 포함하는 receptor tyrosine ki

nase의 erbB 그룹에 속하는 수용체이다. 표피성장인자수용체의 과발현은 다양한 종류의 암, 특히 두경부편평세포암 에서 예후를 악화시킨다고 알려져 있다. 이에 저자들은 하인두편평세포암에서 표피성장인자수용체의 발현 및 분포를 확인하고, 하인두암에서 표피성장인자(EGF)가 암세포의 증식과 침습에 미치는 영향에 대해 알아보고자 하였다.

대상 및 방법

57명의 하인두편평세포암 환자의 조직에서 표피성장인자수용체의 발현을 면역화학적염색을 통해 확인하고, 이에 대해 임상병리학적 요인과 생존율에 대한 분석을 시행하고, 일부 환자의 정상 및 암조직에서 Western blot을 시행하 였다. 하인두편평세포암 세포주인 FaDu에서 proliferative assay, colony dispersion, wound healing assay, invasion assay를 시행하여, 하인두암의 진행에서 표피성장인자의 역할에 대하여 분석하였다. 또한 RT-PCR과 Zymography를 통하여 Matrix metalloproteinase(MMP)-2, 9의 발현을 확인하였다.

결 과

63.2%의 하인두편평세포암 조직에서 표피성장인자수용체의 발현이 확인되었다. 표피성장인자수용체의 발현은 정상조직에서 비하여 하인두암 조직에서 유의하게 증가되어 있었으며, 병리학적 병기(S=0.022)가 올라갈수록 유의 하게 증가하였으나, 증례수의 제한으로 생존율에서는 통계적 유의성을 얻지는 못했다(S=0.053). LQYLWUR의 결과로 표피성장인자를 FaDu 세포주에 처리하였을 때, FaDu 세포주의 증식이 유의하게 증가되었으며(S<0.05), Transwell invasion chamber상 침습의 증가가 확인되었다(S<0.05). RT-PCR과 zymogram 실험상 표피성장인자처리시 FaDu

5HFHLYHG$SULO5HYLVHG$SULO$FFHSWHG$SULO

교신저자 : 김철호, 442-749 경기도 수원시 영통구 원천동 산 5 아주대학교 의과대학 이비인후과학교실 전화 : (031) 219-5269 ・ 전송 : (031) 219-5264 ・ E-mail : ostium@ajou.ac.kr

online



‹



0/



&RPP

(2)

-  -

Introduction

:LWKRYHUFDVHVZRUOGZLGHDQGDKLJKPRUWDOLW\

UDWHKHDGDQGQHFNVTXDPRXVFHOOFDUFLQRPD +16&& LV

WKHVL[WKPRVWFRPPRQFDQFHULQPHQ(YHQZLWKLPSURYHG

WUHDWPHQWVWKHRYHUDOOVXUYLYDOUDWHKDVEHHQOHVVWKDQ

IRUWKHSDVW\HDUV $PRQJFDQFHUVRIWKHKHDGDQGQHFN

K\SRSKDU\QJHDOFDUFLQRPDKDVYHU\KLJKLQYDVLRQDQGPH

WDVWDVLVUDWHVPDNLQJORFRUHJLRQDOFRQWURORIWKHVHFDQFHUV

GLIILFXOW7KH\HDURYHUDOOVXUYLYDOUDWHIRUDOOSDWLHQWVZLWK

K\SRSKDU\QJHDOFDUFLQRPDLVRQO\ZKLFKLVHVVHQWLDO

O\XQFKDQJHGIURPWKHUDWHUHFRUGHGWZRGHFDGHVDJRLQVSLWH

RIYDULRXVWUHDWPHQWWULDOV$QXQGHUVWDQGLQJRIWKHPHGLD

WRUVRIWKHFULWLFDOVWHSVLQWKHPHWDVWDWLFSURFHVVLVHVVHQWLDO

IRUWKHGHYHORSPHQWRIWDUJHWHGWKHUDSLHVIRUK\SRSKDU\Q

JHDOFDUFLQRPD

3DWLHQWVZLWKDGYDQFHGK\SRSKDU\QJHDOFDUFLQRPDDUHDW

JUHDWHVWULVNIRUUHFXUUHQFHEXWWKHWXPRUQRGHPHWDVWDVLV

710 V\VWHPIRUWXPRUVWDJLQJLVLQDGHTXDWHIRUGLVWLQ

JXLVKLQJRXWFRPHDQGWDLORULQJWKHUDS\LQWKHVHSDWLHQWV7KH

FKDUDFWHUL]DWLRQRIWKHPROHFXODUPHFKDQLVPVLQYROYHGLQ

WKHSDWKRJHQHVLVRIK\SRSKDU\QJHDOFDUFLQRPDKDVEHHQ

XQGHUWDNHQWRGHYHORSQHZDSSURDFKHVIRULGHQWLI\LQJSD

WLHQWVDWKLJKHVWULVNIRUSURJUHVVLRQRUUHFXUUHQFHRIGLVHDVH

DQGWRVHOHFWSDWLHQWVZKRFRXOGEHQHILWIURPPXOWLPRGDODQG

PROHFXODUO\WDUJHWHGWKHUDSLHV

5HFHQWUHVHDUFKHIIRUWVKDYHDWWHPSWHGWRH[SORLWELRORJLF

GLIIHUHQFHVWKDWPD\H[LVWEHWZHHQQRUPDODQGPDOLJQDQW

FHOOVWRGHYHORSWXPRUVSHFLILFWKHUDSLHV7KHHSLGHUPDO

JURZWKIDFWRU (*) DQGLWVUHFHSWRU (*)5(UE%RU+(5

 ZHUHQRWRQO\VKRZQWRSOD\DQLQIOXHQWLDOUROHLQFHOOXODU

JURZWKDQGGLIIHUHQWLDWLRQLQKHDOWK\WLVVXHVEXWDOVRLQWXPRUL

JHQHVLVDQGWKHSURJUHVVLRQRIPDOLJQDQWGLVHDVH ,QDGGL

WLRQWRH[SUHVVLRQRQWKHVXUIDFHRIKHDOWK\FHOOVWKH(*)5

LVFRPPRQO\H[SUHVVHGDWKLJKOHYHOVLQDYDULHW\RIHSLWKHOL

DOWXPRUVLQFOXGLQJ+16&&7KHDEHUUDQWDFWLYDWLRQRIWKH

(*)5OHDGVWRHQKDQFHGSUROLIHUDWLRQDQGRWKHUWXPRUSUR

PRWLQJDFWLYLWLHVZKLFKSURYLGHVDVWURQJUDWLRQDOHWRWDUJHW

WKLVUHFHSWRU'XULQJWKHSDVWGHFDGHLQWHQVHUHVHDUFKKDV

LQLWLDWHGDQHZHUDRIFDQFHUWUHDWPHQWWKDWRIPROHFXODUWKHU

DSHXWLFV7RGD\WKH(*)5LVDSULPHWDUJHWIRUQHZDQWLFDQ

FHUWKHUDSLHVZLWKDEURDGUDQJHRILQKLELWRUVFXUUHQWO\XQGHU

LQYHVWLJDWLRQ 3URPLVLQJSUHFOLQLFDOVWXGLHVKDYHSURPSWHG

WKHGHYHORSPHQWRIFOLQLFDOWULDOVWHVWLQJ(*)5LQKLELWRUVDV

VLQJOHDJHQWWKHUDS\RULQFRPELQDWLRQZLWKFRQYHQWLRQDOF\

WRWR[LFWKHUDSLHVZLWKUHVSRQVHUDWHVORZHUWKDQDQWLFLSDWHG

LQWKHDGYDQFHGGLVHDVHVHWWLQJ7KHFOHDUHVWEHQHILWRI(*)5

LQKLELWRUWUHDWPHQWWRGDWHLVQRWHGZKHQLWLVFRPELQHGZLWK

UDGLDWLRQWKHUDS\WRWUHDWORFDOO\DGYDQFHG+16&& ,QQRUPDOFHOOVWKHH[SUHVVLRQRI(*)5UDQJHVIURP

WRUHFHSWRUVSHUFHOO ,Q+16&&(*)5DQGLWVOL

JDQG(*)DUHRYHUH[SUHVVHGLQ-RIFDVHV ;WKHFRU

UHVSRQGLQJPDJQLWXGHVRILQFUHDVHDUHIROG S= DQG

IROG S= UHVSHFWLYHO\FRPSDUHGWRFRQWUROV 7KH

QDWXUHRIWKLVRYHUH[SUHVVLRQLVWKRXJKWWRUHVXOWIURPHQKDQFHG

WUDQVFULSWLRQZLWKQRDSSDUHQWFKDQJHLQP51$VWDELOLW\ 

JHQHDPSOLILFDWLRQKDVEHHQREVHUYHGOHVVIUHTXHQWO\2YHU

H[SUHVVLRQRI(*)5LVREVHUYHGLQWRRI+16&&V

VWXGLHG *UDQGLVHWDOGHPRQVWUDWHGWKDW(*)5RYHUH[SUHV

VLRQSURYLGHGLQGHSHQGHQWSURJQRVWLFYDOXHIRUERWKORFDOFRQ

WURODQGVXUYLYDOLQKHDGDQGQHFNVTXDPRXVFDUFLQRPD

SDWLHQWVWUHDWHGZLWKVXUJLFDOUHVHFWLRQSRVWRSHUDWLYHUDGLR

WKHUDS\ (*)5RYHUH[SUHVVLRQZDVDOVRDVVRFLDWHGZLWKERWK

DQLQFUHDVHGULVNRIORFDOUHODSVHDQGDQDGYHUVHRYHUDOOVXU

YLYDOLQGHSHQGHQWRIWXPRUVWDJH

7KHUHIRUHZHLQYHVWLJDWHGWKHH[SUHVVLRQDQGGLVWULEXWLRQ

RIWKH(*)5LQK\SRSKDU\QJHDOVTXDPRXVFHOOFDUFLQRPD

E\LPPXQRKLVWRFKHPLVWU\DQGWKHHIIHFWRI(*)LQSURJUHVVLRQ

RIK\SRSKDU\QJHDO6&&LQDK\SRSKDU\QJHDO6&&FHOOOLQH

Materials and Methods

1. Patients

)LIW\VHYHQSDWLHQWVDGPLWWHGIRUK\SRSKDU\QJHDOVTXDPRXV

FHOOFDUFLQRPDEHWZHHQDQGDW$MRX8QLYHUVLW\

+RVSLWDODQG<RQVHL8QLYHUVLW\0HGLFDO&HQWHULQ.RUHDZHUH

HQUROOHGLQWKLVVWXG\6XUJLFDOO\UHPRYHGVSHFLPHQVRIK\

SRSKDU\QJHDOVTXDPRXVFHOOFDUFLQRPDH[FOXGLQJFDUFLQR

PDLQVLWXDQGYHUUXFRXVFDUFLQRPDZHUHXVHG1RQHRIWKH

SDWLHQWVKDGXQGHUJRQHUDGLRWKHUDS\RUFKHPRWKHUDS\EHIRUH

VXUJLFDOH[FLVLRQ7KHWXPRUVZHUHFODVVLILHGDFFRUGLQJWRWKH

세포주의 MMP-2, 9이 발현이 증가되고 활성화되는 것이 확인하였다.

결 론

본 연구에서 표피성장인자수용체의 과발현이 하인두암의 예후 인자로서의 가능성을 확인하였고, 표피성장인자가 하인두편평세포암의 증식과 침습에 관여하는 것을 확인하였다.

중심 단어:표피성장인자수용체・표피성장인자・하인두편평세포암・침습・예후.

(3)

-  -

$-&&710FODVVLILFDWLRQV\VWHP7KHDYHUDJHDJHDW

FOLQLFDORQVHWZDV\HDUVZLWKDUDQJHRI-\HDUV6L[

SDWLHQWVKDGVWDJH,RU,,GLVHDVHDQGSDWLHQWVKDGVWDJH,,,

RU,9FDQFHU7KHKLVWRORJLFW\SLQJZDVEDVHGRQWKH:RUOG

+HDOWK2UJDQL]DWLRQ :+2 V\VWHP2IWKHWXPRUVZHUH

ZHOOGLIIHUHQWLDWHGZHUHPRGHUDWHO\GLIIHUHQWLDWHGDQG

ZHUHSRRUO\GLIIHUHQWLDWHG

2. Cell culture

)D'XFHOOVDK\SRSKDU\QJHDOFDQFHUFHOOOLQHZHUHREWDLQHG

IURPWKH$PHULFDQ7\SH&XOWXUH&ROOHFWLRQ $7&&0DQDVVDV

9$86$ DQGFXOWXUHGLQ(DJOH¶VPLQLPXPHVVHQWLDOPHGLXP

(0(0 FRQWDLQLQJP01D+&2IHWDOERYLQHVHUXP

)%6 JOXWDPLQHHVVHQWLDODPLQRDFLGVYLWDPLQ(DQG

VWUHSWRP\FLQDW℃XQGHUD&2DWPRVSKHUH

3. Immunohistochemistry

)RUPDOLQIL[HGSDUDIILQHPEHGGHGWLVVXHZDVFXWLQWR

μPVHFWLRQVDQGWKHQGHZD[HGDQGUHK\GUDWHGYLDVHULDO

SDVVDJHWKURXJK[\OHQHDQGDJUDGHGVHULHVRIHWKDQRO(Q

GRJHQRXVSHUR[LGDVHDFWLYLW\ZDVEORFNHGE\LQFXEDWLRQIRU

PLQLQK\GURJHQSHUR[LGHLQPHWKDQRO7KHSULPDU\

DQWLERGLHVZHUHKXPDQ(*)5SRO\FORQDODQWLERGLHV &HOO

6LJQDOLQJ7HFKQRORJ\'DQYHUV0$86$ XVHGDWDFRQFHQ

WUDWLRQRIμJP/3ULPDU\DQWLERG\LQFXEDWLRQVZHUHFDU

ULHGRXWIRUKDW℃7KHVHFWLRQVZHUHH[WHQVLYHO\ZDVKHG

LQSKRVSKDWHEXIIHUHGVDOLQH 3%6 DQGWKHQLQFXEDWHGZLWK

WKHDSSURSULDWHELRWLQ\ODWHGVHFRQGDU\DQWLERG\IROORZHGE\

DYLGLQSHUR[LGDVH*RDWDQGUDEELW9HFWDVWDLQ(OLWH,PPXQR

SHUR[LGDVH.LWV 9HFWRU/DERUDWRULHV%XUOLQJDPH&$86$  ZHUHSXUFKDVHGIRUWKLVSXUSRVHDQGXVHGLQDFFRUGDQFHZLWK

PDQXIDFWXUHU¶VLQVWUXFWLRQV7KHFKURPRJHQLFUHDFWLRQZDV

FDUULHGRXWZLWK¶GLDPLQREHQ]LGLQHLQDSHUR[LGDVHVXE

VWUDWHVROXWLRQDQGODVWHGPLQ+HPDWR[\OLQHZDVXVHGIRUQX

FOHDUVWDLQLQJ)RUHDFKH[SHULPHQWQHJDWLYHFRQWUROVRPLW

WLQJHLWKHUSULPDU\RUVHFRQGDU\DQWLERGLHVZHUHLQFOXGHGWR

H[DPLQHQRQVSHFLILFVWDLQLQJ7KHVOLGHVZHUHUHYLHZHGE\DW

OHDVWWZRSDWKRORJLVWVDQGVFRUHGVHPLTXDQWLWDWLYHO\DVIRO

ORZV QRVWDLQLQJ±GHILQLWHEXWZHDNVWDLQLQJ+PRGHU

DWHVWDLQLQJDQG++VWURQJVWDLQLQJ7XPRUVDPSOHVVFRUHG

SRVLWLYHLIJLYHQD+RU++DQGLIPRUHWKDQRIWKHFDQ

FHUFHOOVZHUHVWDLQHG

4. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis

7RWDO51$IURPIUHVKK\SRSKDU\QJHDOFDQFHUWLVVXHVDQG

)D'XFHOOVZDVH[WUDFWHGXVLQJ75,]ROŠ ,QYLWURJHQ%9*URQ

LQJHQ7KH1HWKHUODQGV F'1$ZDVSUHSDUHGXVLQJWKH2P

QLVFULSW5HYHUVH7UDQVFULSWDVHNLW 4LDJHQ+LOGHQ*HUPDQ\ 

DFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV7RGHWHUPLQH

WKHHIIHFWVRI(*)FHOOVZHUHWUHDWHGZLWK(*) QJ

P/ 7KHVHTXHQFHVRI3&5SULPHUVZHUHDVIROORZV (*

)5)¶&$$$7$$$$&&**$&7*$$*¶(*)55¶

*7&$*777&7**&$*77&7&¶(*))¶7**$$*&&77

7$7$*$*&$*¶(*)5¶77**&7$7&&$$$77*7

&77¶3&5SURGXFWVZHUHVHSDUDWHGE\HOHFWURSKRUHVLVLQ

DJDURVHJHOVDQGZHUHGHWHFWHGXQGHU89OLJKW %LR5DG

+HUFXOHV&$86$ 

5. Western blot analysis

&HOOVZHUHZDVKHGZLWK3%6SODFHGLQUDGLRLPPXQRSUH

FLSLWDWLRQ 5,3$ EXIIHUFRQWDLQLQJP01D&O13

P07ULV+&O S+ P0('7$GHR[\FKRODWH

μJRISKHQ\OPHWK\OVXOIRQ\OIOXRULGHDQGμJP/OHX

SHSWLQDQGWKHPL[WXUHZDVKRPRJHQL]HG7KHUHDFWLRQPL[

WXUHZDVFHQWULIXJHGDWUSPIRUPLQDW℃DQGWKH

VXSHUQDWDQWZDVXVHGIRU:HVWHUQEORWDQDO\VLV3URWHLQFRQ

FHQWUDWLRQZDVPHDVXUHGXVLQJWKH%LR5DGSURWHLQDVVD\6R

GLXPGRGHF\OVXOIDWH 6'6 SRO\DFU\ODPLGHJHOHOHFWURSKRUHVLV

3$*( ZDVXVHGWRVHSDUDWHμJRISURWHLQSHUZHOODQGWKH

EDQGVZHUHWUDQVIHUUHGWRDQLWURFHOOXORVHILOWHU $PHUVKDP

3LVFDWDZD\1-86$ 7KHPHPEUDQHZDVLQFXEDWHGZLWKVSH

FLILFDQWLERGLHVRYHUQLJKWDW℃7KHPHPEUDQHZDVWKHQ

ZDVKHGZLWK7ULVEXIIHUHGVDOLQH 7%6 FRQWDLQLQJ7ZHHQ

DQGUHDFWHGZLWKSHUR[LGDVHFRQMXJDWHGGRQNH\DQWL

UDEELWDQWLERG\ $PHUVKDP RUGRQNH\DQWLPRXVHDQWLERG\

$PHUVKDP 7KHPHPEUDQHZDVGHYHORSHGXVLQJWKH(Q

KDQFHG&KHPLOXPLQHVFHQFH'HWHFWLRQ6\VWHP (&/ $PHU

VKDP DQG;UD\ILOP

6. Proliferation assay

)D'XFHOOVZHUHSODWHGLQFXOWXUHSODWHV &RVWDU&DPEULGJH

0$86$ DWDGHQVLW\RIDSSUR[LPDWHO\×ZHOOLQWKH

DEVHQFHRIVHUXP(*) QJP/ ZDVDGGHGDQGFHOOV

ZHUHFXOWXUHGIRUGD\V&HOOVZHUHFRXQWHGXVLQJDKHPR

F\WRPHWHURQGD\VDQG6HYHQVHSDUDWHH[SHULPHQWV

ZHUHSHUIRUPHGWRREWDLQVWDWLVWLFDOVLJQLILFDQFH

7. Colony dispersion analysis

)D'XFHOOVZHUHVXEFXOWXUHGDQGPDLQWDLQHGLQJURZWKPH

GLXPXQWLOFRORQLHVFRQWDLQLQJPRUHWKDQFHOOVZHUHHVWDE

OLVKHG&XOWXUHVZHUHWKHQGHSULYHGRIJURZWKIDFWRUVDQG

VHUXPIRUKSULRUWRWUHDWPHQWZLWK(*) QJP/ IRU

WKHLQGLFDWHGWLPHV (*)WUHDWPHQWRIWKHFHOOVZDVSUHFHGHG

E\DKSUHWUHDWPHQWZLWKPLWRP\FLQ& μJP/ &RORQ\GLV

SHUVLRQZDVGRFXPHQWHGE\SKRWRJUDSK\DWDQGK

8. Wound healing assay

)D'XFHOOVZHUHSODWHGLQFXOWXUHSODWHVDWDGHQVLW\RI

(4)

-  - DSSUR[LPDWHO\×ZHOOLQWKHDEVHQFHRIVHUXP&RQIOX

HQWFHOOPRQROD\HUVZHUHWKHQGHSULYHGRIJURZWKIDFWRUV

IRUKDQGDFHOOIUHHDUHDZDVLQWURGXFHGE\VFUDSLQJWKH

PRQROD\HUZLWKDVWHULOHSLSHWWHWLSIROORZHGE\H[WHQVLYH

ZDVKLQJWRUHPRYHFHOOXODUGHEULV,QYLWURUHHSLWKHOLDOL]DWLRQ

ZDVPRQLWRUHGE\WKHUHSRSXODWLRQRIWKHFOHDUHGDUHDZLWK

FHOOVRYHUWLPH7RGHWHUPLQHWKHHIIHFWRI(*)FHOOVZHUH

WUHDWHGZLWKDQGQJP/(*):RXQGKHDOLQJZDV

GRFXPHQWHGE\SKRWRJUDSK\DWDQGK)RUREMHF

WLYHPHDVXUHPHQWVWKHGLVWDQFHEHWZHHQERWKVLGHVZDVPHD

VXUHGE\DFRPSXWHUFDOFXODWRUDWILYHSRLQWV SHURQHILHOG  DWK7KHDYHUDJHGLVWDQFHDWVHYHQILHOGVZDVFRPSDUHGZLWK

HDFKRWKHU FRQWUROYV(*)WUHDWPHQWJURXS (*)QJP/

YV(*)QJP/ 

9. Invasion assay

7UDQVZHOOFKDPEHUV &RVWDU ZHUHXVHGWRYHULI\WKHGHJUHH

RILQYDVLYHQHVVGHSHQGLQJRQWKHDGPLQLVWUDWLRQRI(*))LUVW

W\SH,FROODJHQ μJILOWHU PHOWHGLQμ/(0(0ZDVSRXUHG

LQWRWKHXSSHUSDUWRIDSRO\HWK\OHQHILOWHU μPSRUHVL]H 

FRDWLQJZDVFDUULHGRXWLQDODPLQDUIORZKRRGIRURQHQLJKW

7KHQμ/RI)%6PHGLXPZDVSODFHGLQWRWKHORZHU

SDUWRIHDFKZHOODQGWKHZHOOVZHUHDGMXVWHGWR(*)FRQFHQ

WUDWLRQVRIDQGQJP/$IWHUSUHWUHDWPHQWZLWKPLWR

P\FLQ& μJP/ IRUPLQFHOOV LQμ/RIJURZWK

PHGLXP ZHUHDOORZHGWRDWWDFKHGWRWKHWRSRIWKHILOWHURI

WKHXSSHUZHOO$IWHUWKLVFKDPEHUZDVLQFXEDWHGLQ&2 DW℃IRUKWKHILOWHURIWKHXSSHUZHOOZDVUHPRYHGDQG

WKHFHOOVZHUHSDVVHGWKURXJKWKHSRUH7KHDWWDFKHGFHOOVRQ

WKHORZHUSDUWZHUHG\HGZLWKKHPDWR[\OLQDQGFRXQWHGXQ

GHUDOLJKWPLFURVFRSH

10. RT-PCR of MMP-2 and MMP-9

8VLQJ-PJRIIUR]HQ)D'XFHOOV51$ZDVSUHSDUHG

DVGHVFULEHGDERYH7KHSULPHUSDLUVXVHGIRU003DQG

003ZHUHDVIROORZV 003)¶$&&7**$7*&&

*7&*7**$&¶  0035 ¶7*7**&$*&$&

&$***&$*&¶ 003)¶****$$*$7*&7*&7

*77&$¶ DQG0035¶**7&&&$*7****$7

77$&$¶$IWHUGHQDWXUDWLRQIRUPLQDW℃WKHVDPSOHV

ZHUHDPSOLILHGE\3&5IRUF\FOHVRIVDW℃VDW

℃DQGVDW℃ZLWKH[WHQVLRQIRUPLQDW℃

11. Zymography of MMP-2 and MMP-9

&XOWXUHVZHUHGHSULYHGRIJURZWKIDFWRUVDQGVHUXPIRU

KSULRUWRWUHDWPHQWZLWK(*) QJP/ IRUWKHLQ

GLFDWHGSHULRGVRIWLPH$IWHUTXDQWLILFDWLRQRIWKHSURWHLQ

LQWKHVXSHUQDWDQWμJRISURWHLQIURPHDFKVDPSOHZDV

PL[HGZLWKμ/SDPLQRSKHQ\OPHUFXULFDFHWDWH $30$ 

DQGWKHVDPSOHVZHUHDFWLYDWHGIRUKDW℃&\WRSODVP

VDPSOHVZHUHREWDLQHGDIWHUKXVLQJWKH0LJKW\6OLP70

6; +RHIHU6DQ)UDQFLVFR&$86$ SURFHVV(DFKμ/

VDPSOHZDVSODFHGLQVDPSOHEXIIHUIRUPLQDQGWKHQHOHF

WURSKRUHVHGLQDSRO\DFU\ODPLGHJHODW9IRUPLQDW

℃XVLQJWKH1RYH[;&HOO,,7KHJHOZDVLQFXEDWHGLQUHQD

WXUDWLRQEXIIHUIRUPLQDWURRPWHPSHUDWXUHDQGWKHQLQ

FXEDWHGLQP/RIGHYHORSLQJEXIIHUDW℃IRUKZLWK

OLJKWVKDNLQJ7KHJHOZDVVWDLQHGZLWK&RRPDVVLHEOXHIRU

KDQGZDVKHGZLWKZDWHU$IWHUGHFRORUL]DWLRQLQP/PHWK

DQROP/DFHWLFDFLGDQGP/GLVWLOOHGZDWHUFHOOLP

DJHVZHUHWDNHQHYHU\PLQXVLQJDQLPDJHDQDO\]HU

12. Statistical methods

3HDUVRQ¶VFKLVTXDUHWHVWDQG)LVKHU¶VH[DFWWHVWZHUHXVHG

IRUVWDWLVWLFDODQDO\VHVRILPPXQRKLVWRFKHPLFDOGDWD3D

WLHQWVXUYLYDOUDWHVZHUHFDOFXODWHGXVLQJWKH.DSODQ0HLHU

PHWKRGDQGVWDWLVWLFDOO\VLJQLILFDQWGLIIHUHQFHVLQVXUYLYDO

ZHUHLGHQWLILHGXVLQJWKHORJUDQNWHVW6WXGHQW¶VWWHVWDQG

RQHZD\DQDO\VLVRIYDULDQFH $129$ IRUWKHLQYDVLRQDV

VD\ ZHUHDOVRXVHGIRUDQDO\VHV$OOVWDWLVWLFDODQDO\VHVZHUH

FRQGXFWHGXVLQJ6366VRIWZDUH 6366,QF&KLFDJR,/

86$ $SYDOXHRIOHVVWKDQZDVFRQVLGHUHGVWDWLVWLFDO

O\VLJQLILFDQW

Results

1. Expression of EGFR in human hypopharyngeal cancer tissue

(*)5RYHUH[SUHVVLRQZDVREVHUYHGLQ  RIK\

SRSKDU\QJHDOFDQFHUWLVVXHV,QPRVWRIWKHVSHFLPHQV(*)5

H[SUHVVLRQZDVSULPDULO\REVHUYHGLQWKHFHOOPHPEUDQHDQG

F\WRSODVPRIFDQFHUFHOOV )LJ$ (*)5H[SUHVVLRQZDV

REVHUYHGLQRISDWLHQWVZLWKWXPRUVOHVVWKDQFPLQ

GLDPHWHU VWDJH7RU7 DQGLQRISDWLHQWVZLWKWX

PRUVODUJHUWKDQFPLQGLDPHWHU VWDJH7DQG7 $OWKRXJK

(*)5H[SUHVVLRQDSSHDUHGWRLQFUHDVHZLWKWXPRUVL]HWKHVH

UHVXOWVZHUHQRWVWDWLVWLFDOO\VLJQLILFDQW 7DEOH ,QFDVHV

ZKHQQRO\PSKQRGHPHWDVWDVLVRFFXUUHG(*)5H[SUHVVLRQ

ZDVREVHUYHGLQQLQHRXWRIFDVHV  +RZHYHUDVWD

WLVWLFDOO\QRQVLJQLILFDQWLQFUHDVHLQ(*)5H[SUHVVLRQZDV

REVHUYHGLQRISDWLHQWV  ZLWKO\PSKQRGHPHWDV

WDVLV(*)5H[SUHVVLRQDOVRDSSHDUHGWRLQFUHDVHLQFDVHVRI

GLVWDQWPHWDVWDVLV  ZLWKDVLJQLILFDQWGLIIHUHQFHFRP

SDUHGWRWKRVHZLWKRXWGLVWDQWPHWDVWDVLV  (*)5H[

SUHVVLRQZDVSRVLWLYHLQ  DQG  RIHDUO\

DQGDGYDQFHGVWDJHFDUFLQRPDVUHVSHFWLYHO\GHPRQVWUDWLQJ

DVLJQLILFDQWLQFUHDVHLQ(*)5H[SUHVVLRQDFFRUGLQJWRWXPRU

(5)

-  - VWDJH S= 3DWKRORJLFFHOOGLIIHUHQWLDWLRQGLGQRWVHHP

WRDIIHFW(*)5H[SUHVVLRQ1RVWDWLVWLFDOO\VLJQLILFDQWGLIIHU

HQFHZDVREVHUYHGEHWZHHQJURXSVZLWKDQGZLWKRXWUHFXU

UHQFH DQGUHVSHFWLYHO\ 2IWKHSDWLHQWV   GLHGGXULQJWKHIROORZXSSHULRG7KHFDXVHRIGHDWKZDVOR

FDOUHFXUUHQFHLQFDVHVDQGGLVWDQWPHWDVWDVLVLQQLQHFDV

HV6XUYLYDODQDO\VLVZDVSHUIRUPHGXVLQJWKH.DSODQ0HLHU

PHWKRGDQGWKHVWDWLVWLFDOVLJQLILFDQFHZDVHYDOXDWHGE\WKH

ORJUDQNWHVW )LJ% $OWKRXJKDGLIIHUHQFHLQVXUYLYDOUDWHV

DSSHDUHGWRH[LVWEHWZHHQWKHJURXSVZLWKQHJDWLYHDQGSRVL

WLYH(*)5H[SUHVVLRQWKHSYDOXHZDV

2. Western blot analysis of hypopharyngeal cancer tissues and RT-PCR and Western blot analysis of the human hypopharyngeal cancer cell line

:HVWHUQEORWWLQJZDVSHUIRUPHGRQWKUHHSDWLHQWVDQG

(*)5ZDVVWURQJO\H[SUHVVHGLQFDUFLQRPDFHOOVDQGQRWLQ

QRUPDOWLVVXHV )LJ 7KHH[SUHVVLRQRI(*)5P51$LQ

)D'XFHOOVZDVGHWHFWHGE\573&5DQGWKH(*)5SURWHLQ

ZDVGHWHFWHGE\:HVWHUQEORWWLQJ+RZHYHU(*)ZDVQRWGH

7DEOH&RUUHODWLRQEHWZHHQWKHH[SUHVVLRQSDWWHUQRI(*)5DQGFOLQLFRSDWKRORJLFIDFWRUV

9DULDEOHV ([SUHVVLRQRI(*)5()

SYDOXH 1HJDWLYH(²+) 3RVLWLYH(+++++)

7 (Q=) () () 

(Q=) () ()

1 –(Q=) () () 

+(Q=) () ()

0 –(Q=) () () 

+(Q=) () ()

3DWKRORJLFVWDJH ,,,(Q=) () () 

,,,,9(Q=) () ()

3DWKRORJLFJUDGHV :HOO(Q=) () () 

0RGHUDWH(Q=) () ()

3RRU(Q=) () ()

5HFXUUHQFH <HV(Q=) () () 

1R(Q=) () ()

*:&DOFXODWHGE\3HDUVRQ·VFKLVTXDUHWHVW(S<)**:&DOFXODWHGE\)LVKHU·VH[DFWWHVW(S<)

)LJ($),PPXQRKLVWRFKHPLVWU\:3DUDIÀQVHFWLRQVRIK\SRSKDU\QJHDOFDUFLQRPDVLPPXQRVWDLQHGIRU(*)5(*)5VWDLQLQJZDVSUL

PDULO\REVHUYHGLQWKHPHPEUDQHRIWKHFDQFHUFHOOVEXWZDVREVHUYHGRFFDVLRQDOO\LQERWKWKHPHPEUDQHDQGF\WRSODVPRI

FDQFHUFHOOV(×PDJQLÀFDWLRQ)(D)QRVWDLQLQJ(E)GHÀQLWHEXWZHDNVWDLQLQJ(±)(F)PRGHUDWHVWDLQLQJ(+)(G)VWURQJVWDLQLQJ(++)

(%)6XUYLYDOUDWH:)LYH\HDUVXUYLYDORISDWLHQWVZLWKK\SRSKDU\QJHDOFDUFLQRPDVDFFRUGLQJWR(*)5H[SUHVVLRQ6XUYLYDOZDVVLJ

QLÀFDQWO\SRRUHULQSDWLHQWVZLWKSRVLWLYH(*)5H[SUHVVLRQFRPSDUHGWRWKRVHZLWKQHJDWLYH(*)5H[SUHVVLRQ(S=)















6XUYBWLPH

,PPXQRKLV (*)5(-)

(*)5(+)





FHQVRUHG

FHQVRUHG S=

6XUYLYDOIXQFWLRQV

&XPVXUYLYDO

%

$

D E

F G

)LJ([SUHVVLRQRI(*)5LQKXPDQK\SRSKDU\QJHDOFDQFHUWLV

VXHV:HVWHUQEORWWLQJGHPRQVWUDWHGWKDW(*)5ZDVVWURQJO\H[

SUHVVHGLQFDUFLQRPDVFRPSDUHGWRQRUPDOWLVVXHV1:1RUPDOWLV

VXH&:&DQFHUWLVVXH

(*)5

1&1&1&

$FWLQ

(6)

-  - WHFWHGE\HLWKHU573&5RU:HVWHUQEORWWLQJ )LJ 

3. Effect of EGF on proliferation of FaDu cells

(*)VWLPXODWHVWKHSUROLIHUDWLRQRIYDULRXVFDQFHUFHOOV

^$UWHDJD`7KHUHIRUHZHSHUIRUPHGDSUROLIHUDWLRQDVVD\

WRGHWHUPLQHZKHWKHU(*)DOVRVWLPXODWHVWKHSUROLIHUDWLRQRI

)D'XFHOOV$VVKRZQLQ)LJ(*)DWQJP/DQGQJP/

VWLPXODWHGWKHSUROLIHUDWLRQRI)D'XFHOOVRQWKHWKLUGDQGILIWK

GD\V S< UHVSHFWLYHO\0RUHRYHU(*)DWQJP/LQ

FUHDVHGSUROLIHUDWLRQWRDJUHDWHUH[WHQWWKDQFHOOVWUHDWHGZLWK

QJP/(*)RQWKHWKLUGGD\ )LJ 

4. Effect of EGF on colony dispersion

(*)LVRQHRIWKHPRVWSRWHQWWXPRUPRWLOLW\IDFWRUVDQG

FRQWULEXWHVWRPHWDVWDVLVE\VWLPXODWLQJWXPRUPRWLOLW\ ,Q

WKHFRQWUROQRVLJQLILFDQWFRORQ\GLVSHUVLRQRFFXUUHGLQWKH

)D'XFHOOV,Q(*)WUHDWHGJURXSVWKH)D'XFHOOVGLVVRFLDW

)LJ6FDWWHUDFWLYLW\RI(*))D'XFHOOVZHUHFXOWXUHG($)ZLWKRXWWUHDWPHQW(FRQWURO)(%)ZLWKQJP/(*)RU(&)ZLWKQJP/(*)

IRUK(RULJLQDOPDJQLÀFDWLRQ×),QWKHFRQWUROJURXSVLJQLÀFDQWFRORQ\GLVSHUVLRQRI)D'XFHOOVGLGQRWRFFXU,Q(*)WUHDWHG

JURXSV(*)VLJQLÀFDQWO\LQFUHDVHGGLVSHUVLRQRI)D'XFHOOV(*)DWQJP/DSSHDUHGWRKDYHDPRUHSRWHQWVFDWWHULQJHIIHFWWKDQ

(*)DWQJP/KDIWHU(*)VWLPXODWLRQ

)LJ3UROLIHUDWLYHDFWLYLW\RI(*)3UROLIHUDWLYHDVVD\RI)D'XFHOOV

DIWHUWUHDWPHQWZLWK(*)IRUGD\V([RJHQRXV(*)VLJQLÀFDQWO\

HQKDQFHGWKHJURZWKRI)D'XFHOOVLQDGRVHGHSHQGHQWPDQQHU

( S<)









3UROLIHUDWLRQDVVD\ 'D\:(*)'D\:(*)'D\:&RQWURO'D\:(*)'D\:(*)'D\:&RQWURO'D\:(*)'D\:(*)'D\:&RQWURO

&RQWURO

*URXSV

(*) (*)

(UURU%DUVVKRZ0HDQ+-6' 6WXGHQW·VWWHVWUHVXOW(SYDOXH)

'D\

&RQWURO(*):

&RQWURO(*):

(*)(*):

'D\

&RQWURO(*):

&RQWURO(*):

(*)(*):

'D\

&RQWURO(*):

&RQWURO(*):

(*)(*):

*URXSV

&RQWURO

(*)QJP/

(*)QJP/

KRXUV

KRXUV

KRXUV

)LJ$QDO\VLVRI(*)DQG(*)5H[SUHVVLRQLQWKH)D'XFHOOOLQH

($)573&5:7KHH[SUHVVLRQRI(*)DQG(*)5P51$ZDVPHD

VXUHGE\573&5LQWKHK\SRSKDU\QJHDOFDQFHUOLQH)D'X(%)

:HVWHUQEORWWLQJ:'HWHFWLRQRIWKH(*)5SURWHLQLQ)D'XFHOOVE\

:HVWHUQEORWWLQJ(*)ZDVQRWGHWHFWHGE\HLWKHU573&5RU:HVW

HUQEORWDQDO\VLV

(*)(ES)

(*)5(ES)

$

$FWLQ.' (*)5 .' (*)(*)(*)

%

(7)

-  - HGKDIWHUWUHDWPHQW )LJ $IWHUKWKHIRUPDWLRQRIDFWLQ

PLFURVSLNHV ILORSRGLD DQGPHPEUDQHUXIIOLQJ ODPHOOLSRGLD  ZHUHREVHUYHGDQGFHOOPRUSKRORJ\VKRZHGVSLQGOHOLNH

IHDWXUHV7KLVUHVXOWVXJJHVWVWKDW(*)PD\EHDVVRFLDWHGZLWK

VFDWWHULQJ$OWKRXJKZHGLGQRWPHDVXUHWKHREMHFWLYHVFDW

WHULQJHIIHFWDFFRUGLQJWRWKHFRQFHQWUDWLRQRI(*)(*)DW

QJP/DSSHDUHGWRSURGXFHDPRUHSRWHQWVFDWWHULQJHIIHFW

WKDQ(*)DWQJP/KDIWHU(*)VWLPXODWLRQ

5. Effect of EGF on wound healing

7RDVVHVVWKHFRQWULEXWLRQVRI(*)WRERWKPLJUDWRU\DQG

SUROLIHUDWLYHDFWLYLWLHVZHSHUIRUPHGDQLQYLWURZRXQGKHDO

LQJDVVD\LQ)D'XFHOOVXVLQJ(*)DWDQGQJP/FRQ

FHQWUDWLRQV([RJHQRXV(*)VLJQLILFDQWO\HQKDQFHGWKHPL

JUDWLRQDQGSUROLIHUDWLRQRI)D'XFHOOVLQGRVHGHSHQGHQW

PDQQHU )LJ (*)DWQJP/OHGWRD±IROGLQ

FUHDVHLQFHOOPLJUDWLRQ S<YVFRQWURO DQG(*)DW

QJP/LQFUHDVHGFHOOPLJUDWLRQ±IROG S<YV

FRQWURO (*)DWQJP/LQFUHDVHGFHOOPLJUDWLRQ±

IROGFRPSDUHGWRFHOOVWUHDWHGZLWKQJP/(*) S<

 

6. Effect of EGFR on cell invasion

$7UDQVZHOOFKDPEHULQYDVLRQDVVD\ZDVSHUIRUPHGXVLQJ

WKH)D'XFHOOOLQHWRGHWHUPLQHZKHWKHU(*)FRQWULEXWHVWR

FHOOLQYDVLYHQHVV)LJGHPRQVWUDWHVWKDW(*)WUHDWPHQW

GRVHGHSHQGHQWO\LQFUHDVHGWKHQXPEHURIFHOOVWKDWLQYDG

HGFRPSDUHGWRXQWUHDWHGFRQWUROV(*)DWQJP/LQ

FUHDVHGFHOOLQYDVLRQE\±IROG S<YVFRQWURO DQG

(*)DWQJP/OHGWRDQ±IROGLQFUHDVHLQFHOOLQYDVLRQ

S<YVFRQWURO (*)DWQJP/LQFUHDVHGFHOOLQYD

VLRQE\±IROGFRPSDUHGWRWKHQJP/(*)WUHDW

PHQWJURXS S< )LJ 

7. RT-PCR of MMP-2 and MMP-9

7RFRQILUPZKHWKHU(*)LQGXFHV003JHQHH[SUHVVLRQ

LQ)D'XFHOOVZHSHUIRUPHG573&5DIWHUWUHDWPHQWRIWKH

FHOOVZLWK(*) QJP/RUQJP/ 003P51$ZDV

PDUNHGO\HOHYDWHGDIWHUWUHDWPHQWRI)D'XFHOOVZLWK(*)

IRUKEXWQRVLJQLILFDQWGLIIHUHQFHZDVGHWHFWHGEHWZHHQ

(*)DWQJP/DQGQJP/573&5VKRZHGDVOLJKWLQ

FUHDVHLQWKHOHYHORI003ZLWK(*)WUHDWPHQWFRPSDUHG

WRWKHFRQWURO )LJ$ 

8. Zymography of MMP-2 and MMP-9

003DFWLYLW\LQFUHDVHGDIWHUKRI(*)WUHDWPHQWFRP

SDUHGWRWKHFRQWUROEXWQRVLJQLILFDQWGLIIHUHQFHZDVRE

VHUYHGEHWZHHQWKHQJP/DQGQJP/(*)JURXSV003

DFWLYLW\DIWHU(*)WUHDWPHQWZDVPDUNHGO\HOHYDWHGDWK

DOWKRXJKQRVLJQLILFDQWGLIIHUHQFHZDVVHHQEHWZHHQ(*)DW

QJP/DQGQJP/ )LJ% 

Discussion

(*)5LVDJO\FRSURWHLQRIN'DHQFRGHGE\DJHQHOR

FDWHGRQFKURPRVRPHS 7KH(*)5LVDPHPEHURIWKH

HUE%IDPLO\RIUHFHSWRUW\URVLQHNLQDVHSURWHLQVZKLFKDOVR

LQFOXGHV+(5QHX HUE% +(5 HUE% DQG+(5 HUE% 

7KHVHUHFHSWRUVDUHFRPSRVHGRIDQH[WUDFHOOXODUOLJDQGELQG

LQJGRPDLQDWUDQVPHPEUDQHOLSRSKLOLFGRPDLQDQGDQLQ

WUDFHOOXODUW\URVLQHNLQDVHGRPDLQDQGZLWKWKHH[FHSWLRQ

RI+(5DOOELQGWRUHFHSWRUVSHFLILFOLJDQGV3KRVSKRU\OD

WLRQRIWKHW\URVLQHNLQDVHGRPDLQIROORZHGE\KRPRGLPHU

L]DWLRQRUKHWHURGLPHUL]DWLRQEHWZHHQGLIIHUHQWUHFHSWRUVRI

$

1R7[

(*)QJP/

(*)QJP/

KRXUV KRXUV

%









:RXQG

&RQWURO(*)(*)

*URXS

6WXGHQW·VWWHVWUHVXOW(SYDOXH)

&RQWURO(*):

&RQWURO(*):

)*)(*):

)LJ:RXQGKHDOLQJDVVD\LQ(*)WUHDWHGFHOOV)D'XFHOOVZHUHSODWHGLQDZHOOSODWHDQGJURZQWRFRQÁXHQF\LQVHUXPFRQWDLQ

LQJPHGLD7KHFHOOVZHUHVWDUYHGRIJURZWKIDFWRUVIRUK7KHPRQROD\HUZDVVFUDWFKHGZLWKDSLSHWWHWLSDQGZDVKHGZLWK3%6

7RHYDOXDWHWKHHIIHFWRI(*)RQERWKPLJUDWRU\DQGSUROLIHUDWLYHDFWLYLWLHV)D'XFHOOVZHUHWUHDWHGZLWK(*)DWDQGQJP/

FRQFHQWUDWLRQV([RJHQRXV(*)HQKDQFHGWKHPLJUDWLRQDQGSUROLIHUDWLRQRI)D'XFHOOVLQDGRVHGHSHQGHQWPDQQHU(S<)($)

0LFURVFRSLFÀQGLQJV; (%)JUDSK

(8)

-  - WKHVDPHIDPLO\OHDGVWRSURWHLQDFWLYDWLRQ 5HFHSWRUGLPHU

L]DWLRQLVSURPRWHGE\OLJDQGELQGLQJKLJKUHFHSWRUGHQVLW\

GXHWRRYHUH[SUHVVLRQDQGPXWDWLRQVLQWKHNLQDVHGRPDLQ

3URWHLQDFWLYDWLRQRQWKHFHOOVXUIDFHRIFDQFHUFHOOVLVEHOLHYHG

WRSURPRWHVLJQDOLQJFDVFDGHVFHOOJURZWKGLIIHUHQWLDWLRQFHOO

VXUYLYDO DSRSWRVLV GUXJDQGUDGLDWLRQVHQVLWLYLW\FHOOF\FOH

SURJUHVVLRQDQGDQJLRJHQHVLV

*URZWKDQGGLIIHUHQWLDWLRQRI+16&&DUHUHJXODWHGE\VHY

)LJ,QGXFWLRQRI003DQG003DFWLYLWLHVE\(*)$:573&5RI003DQG003LQ)D'XFHOOV'HWHFWLRQRI003DQG

003H[SUHVVLRQLQ)D'XFHOOVWUHDWHGIRUKZLWKDQGQJP/(*)([RJHQRXV(*)HQKDQFHG003DQG003H[SUHV

VLRQ%:=\PRJUDSK\)D'XFHOOVZHUHVHUXPGHSULYHGIRUKDQGWKHQLQFXEDWHGZLWKIUHVKPHGLXPFRQWDLQLQJ(*)DWRUQJ

P/FRQFHQWUDWLRQV7KHFRQGLWLRQHGPHGLDZHUHFROOHFWHGDIWHUDQGK7KHVDPSOHVZHUHIUDFWLRQDWHGRQDSRO\DFU\ODPLGH

JHOFRQWDLQLQJJHODWLQDQGD]\PRJUDPZDVGHYHORSHGDVGHVFULEHGLQWKH0DWHULDOVDQGPHWKRGV7KHDQGN'DJHOD

WLQDVHDFWLYLW\EDQGVDUHLQGLFDWHGE\WKHVROLGDUURZV7KHOHYHORI003DQG003DFWLYLW\LQFUHDVHGDIWHU(*)WUHDWPHQWIRU

KFRPSDUHGWRWKHFRQWUROJURXS+RZHYHUQRVLJQLÀFDQWGLIIHUHQFHZDVREVHUYHGEHWZHHQWKHDQGP/(*)WUHDWPHQW

JURXSV

003(ES)

003(ES)

$FWLQ(ES) (*)(*)(*)

$

003

003

(*)(*)(*)

%

003













'HQVLW\

(

)

(*)(*)(*)

003













'HQVLW\

(

)

(*)(*)(*)

)LJ,QYDVLRQDVVD\RI(*)WUHDWHGFHOOV7UDQVZHOOFKDPEHUVZHUHXVHGWRYHULI\WKHOHYHORIFHOOLQYDVLYHQHVV)D'XFHOOVZHUH

VHHGHGRQWKHXSSHUPHPEUDQHLQ(*)DWDQGQJP/FRQFHQWUDWLRQV$IWHUKRILQFXEDWLRQSOXJJHGFHOOVLQWKHμP

SRUHRUFHOOVDWWDFKHGWRWKHXQGHUVXUIDFHPHPEUDQHZHUHFRXQWHGDQGWKHFHOOVDWWDFKHGLQWKHORZHUVHFWLRQZHUHVWDLQHGZLWK

KHPDWR[\OLQDQGFRXQWHGXQGHUDOLJKWPLFURVFRSH7KHEDUVVKRZWKH6'RIWULSOLFDWHVDPSOHV'DWDDUHUHSUHVHQWDWLYHRIWKUHH

VHSDUDWHH[SHULPHQWVZLWKVLPLODUUHVXOWV(*)VLJQLÀFDQWO\SURPRWHGWKHLQYDVLRQRI)D'XFHOOVLQDGRVHGHSHQGHQWPDQQHU

%









,QYDVLRQ

&RQWURO(*)(*)

*URXS

6WXGHQW·VWWHVWUHVXOW(SYDOXH)

&RQWURO(*):

&RQWURO(*):

(*)(*):

$

&RQWURO (*)QJP/ (*)QJP/

(9)

-  - HUDOJURZWKIDFWRUVDQGWKHLUVXUIDFHUHFHSWRUV(*)5LVXS

UHJXODWHGLQVHYHUDOFDUFLQRPDVDQGLVHQFRGHGE\WKHFHUE

%SURWRRQFRJHQH7KLVSURWHLQLVH[SUHVVHGDWDORZOHYHOV

LQPDQ\QRUPDOKXPDQWLVVXHVEXWDFWLYDWLRQRIWKHFHUE%

RQFRJHQHUHVXOWVLQLWVRYHUH[SUHVVLRQDQGLVREVHUYHGLQ

PDQ\KXPDQFDQFHUV ,Q+16&&(*)5LVQRWRQO\DQ

LQGHSHQGHQWSURJQRVWLFIDFWRURIRXWFRPHLQPXOWLYDULDWHDQDO

\VLVEXWDOVRDILUVWFKRLFHWKHUDSHXWLFWDUJHW 7KHUHFHQW

GHPRQVWUDWLRQRIDVLJQLILFDQWVXUYLYDOEHQHILWZKHQFRP

ELQLQJFHWX[LPDEZLWKH[WHUQDOUDGLDWLRQWKHUDS\LVDPDMRU

EUHDNWKURXJKLQWKHPDQDJHPHQWRI+16&& DQGHVWDE

OLVKHVDQHZWUHDWPHQWRSWLRQIRUORFDOO\DGYDQFHG+16&&

7KLVWULDODOVRSURYLGHGDQLPSRUWDQWSURRIRISULQFLSOH

WKDWWDUJHWLQJDSHUWLQHQWVLJQDOLQJSDWKZD\FDQHQKDQFHWKH

UDGLDWLRQUHVSRQVHRIWXPRUV+RZHYHUWKHLPSURYHPHQWLQ

WKHORFRUHJLRQDOFRQWUROUDWHKDVEHHQPRGHVW ZLWKLQWKH

UDQJHDFKLHYHGZLWKFRQFXUUHQWUDGLRWKHUDS\DQGFKHPRWKHU

DS\ DQGPRUHWKDQKDOIRISDWLHQWVUHFHLYLQJUDGLRWKHUDS\

SOXVFHWX[LPDEVWLOOH[SHULHQFHGORFRUHJLRQDOUHODSVH 7KHUH

IRUHDQHHGH[LVWVWRIXUWKHULPSURYHWKHRXWFRPH2QJRLQJ

FOLQLFDOHIIRUWVDUHGHYRWHGWRDGGUHVVZKHWKHUWKHDGGLWLRQ

RIFHWX[LPDEWRFRQFXUUHQWFKHPRUDGLDWLRQFDQ\LHOGDEHWWHU

RXWFRPH LH572*VWXG\ &DQFHUFHOOVUHO\RQVHYHUDO

VRPHWLPHVUHGXQGDQWDFWLYDWLRQSDWKZD\V (*)5LVRQO\RQH

RIWKHP7KHULVNRIWUHDWPHQWIDLOXUHLVKLJKHULIRQO\RQH

UHFHSWRULVWDUJHWHG KHQFHFRPELQLQJEURDGHUUDQJHW\UR

VLQHNLQDVHLQKLELWRUVVXFKDV&,ZKLFKWDUJHWVDOOIRXU

PHPEHUVRIWKH(UEIDPLO\ SDQ(UE% FRXOGLQFUHDVHWUHDW

PHQWVXFFHVV ,QKHDGDQGQHFNFDQFHUSDWLHQWVUHFHLYLQJ

IOXRURXUDFLO(*)5ZDVVKRZQWREHDWXPRUSDUDPHWHU

ZLWKWKHKLJKHVWSURJQRVWLFLPSDFW 7KHUHODWLRQVKLSEH

WZHHQ(*)5RYHUH[SUHVVLRQDQGLQFUHDVHGWXPRUVL]HDQG

RUWKHORFDOH[WHQWRISULPDU\WXPRUV 7FODVVLILFDWLRQ KDVEHHQ

GHVFULEHGLQSUHYLRXVVWXGLHV ,QDQRWKHUVWXG\PXOWLYDUL

DWHDQDO\VLVVKRZHGWKDW1VWDWXVZDVWKHPRVWSRZHUIXOFOLQ

LFDOSURJQRVWLFIDFWRUDQGWKDWWKH(*)5OHYHORIH[SUHVVLRQ

ZDVDPDMRUSURJQRVWLFIDFWRULQWKHSRSXODWLRQRISDWLHQWV

ZLWKUHVHFWDEOHODU\Q[DQGK\SRSKDU\Q[FDQFHUVWUHDWHGE\

LQGXFWLRQFKHPRWKHUDS\DQGUDGLRWKHUDS\,QVHYHUDOVWXGLHV

(*)5H[SUHVVLRQZDVVXJJHVWHGWREHFRUUHODWHGZLWKSURJ

QRVLVLQDGYDQFHGODU\QJHDOFDUFLQRPD VWDJH,,,DQG,9  

&RQYHUVHO\VWXGLHVKDYHDOVRUHSRUWHGQRVLJQLILFDQWFRUUHOD

WLRQEHWZHHQ(*)5H[SUHVVLRQDQGWXPRUSURJQRVLVLQ+1

6&& 

,QWKLVVWXG\LPPXQRKLVWRFKHPLFDOVWDLQLQJZDVSHUIRUPHG

RQFDVHVRIK\SRSKDU\Q[FDQFHUWRDQDO\]HWKHH[SUHVVLRQ

RI(*)52YHUH[SUHVVLRQRI(*)5ZDVQRWHGLQRIWKH

FDVHV(*)5H[SUHVVLRQZDVVLJQLILFDQWO\HOHYDWHGLQDGYDQFHG

VWDJHWXPRUV)XUWKHUPRUHWKHUDWHRIGLVWDQWPHWDVWDVLVLQ

FUHDVHGZKHQ(*)5ZDVRYHUH[SUHVVHGDQGZHEHOLHYHWKDW

DVWDWLVWLFDOO\VLJQLILFDQWFRUUHODWLRQPD\EHIRXQGZLWKDODUJ

HUVWXG\SRSXODWLRQ%HFDXVH(*)5ZDVPRUHVWURQJO\H[

SUHVVHGLQWKHFDQFHUFHOOV(*)5DFWLYDWLRQLVWKRXJKWWREH

DVVRFLDWHGZLWKWKHSURJUHVVLRQRIFDQFHU,QWKLVVWXG\HYHQ

LQWKHFDVHVZKHQ(*)5H[SUHVVLRQZDVQRWREVHUYHG(*)5

ZDVSUHVXPHGWREHSUHVHQWEXWFRXOGQRWEHREVHUYHGEH

FDXVHLWZDVH[SUHVVHGDWOHYHOVWKDWZHUHXQGHWHFWDEOHE\LP

PXQRKLVWRFKHPLVWU\)XUWKHUVWXGLHVPHDVXULQJWKHFRQFHQ

WUDWLRQRI(*)5LQWKHWLVVXHRUXVLQJ:HVWHUQEORWWLQJWR

GHWHUPLQHWKHUHODWLRQVKLSEHWZHHQWKHFRQFHQWUDWLRQRI(*)

DQG(*)5DQGWKHLUH[SUHVVLRQDUHZDUUDQWHG$OWKRXJKQR

VWDWLVWLFDOVLJQLILFDQFHZDVGHWHFWHGEHWZHHQWKHH[SUHVVLRQ

RI(*)5DQGWKHVXUYLYDOUDWHLQWKLVVWXG\ S= DFRU

UHODWLRQPD\EHUHYHDOHGLQDODUJHUVWXG\SRSXODWLRQ

'HJUDGDWLRQRIWKHH[WUDFHOOXODUPDWUL[ (&0 ZKLFKLVD

QHFHVVDU\VWHSLQWLVVXHUHPRGHOLQJSURFHVVHVVXFKDVZRXQG

KHDOLQJDQGHPEU\RQDOGHYHORSPHQWKDVEHHQDWWULEXWHGWR

SURWHRO\WLFDFWLYLW\RI003V7KHUROHRI(*)5PHGLDWHG

VLJQDOVLQUHJXODWLQJPDWUL[GHJUDGDWLRQLVQRWFRPSOHWHO\

XQGHUVWRRGEXW(*)5LQDFWLYDWLRQKDVEHHQVKRZQWRLP

SDLU003DFWLYLW\GXULQJSDQFUHDWLFDQGFUDQLRIDFLDOGHYHO

RSPHQW:RXQGKHDOLQJLVDQRWKHUUHPRGHOLQJSURFHVVLQ

ZKLFKSURSHUO\FRQWUROOHGVWURPDOHSLWKHOLDOLQWHUDFWLRQVDUH

FUXFLDOWRWKHRXWFRPH,Q(*)5QXOOPLFHHDUO\SUROLIHUD

WLRQDQGPLJUDWLRQRINHUDWLQRF\WHVLVLPSDLUHGUHVXOWLQJLQ

GHOD\HGZRXQGKHDOLQJZKLFKSURYLGHVLQVLJKWLQWRWKHPRGH

RIDFWLRQRI(*)5LQWLVVXHUHPRGHOLQJSURFHVVHV ,QWKLV

VWXG\573&5DIWHU(*)WUHDWPHQWIRUDQGKUHYHDOHG

DPDUNHGLQFUHDVHLQWKHOHYHORI003DQG003,QDG

GLWLRQZHFRQILUPHGE\]\PRJUDSK\WKDWWKHDFWLYLWLHVRI003

DQG003LQFUHDVHGLQWKH(*)WUHDWPHQWJURXS7KHVH

UHVXOWVVXJJHVWWKDWH[RJHQRXV(*)HQKDQFHVWKHH[SUHVVLRQ

DQGDFWLYLW\RI003DQG003

,QVXPPDU\KLJK(*)5H[SUHVVLRQZDVREVHUYHGLQK\

SRSKDU\QJHDOFDQFHUWLVVXHDQGWKHOHYHORI(*)5VLJQLIL

FDQWO\LQFUHDVHGZLWKWXPRUSDWKRORJLFVWDJH0RUHRYHU(*)5

SURWHLQH[SUHVVLRQLQFUHDVHGLQK\SRSKDU\QJHDOFDQFHUFHOOV

FRPSDUHGWRQRUPDOFHOOVDQGH[RJHQRXV(*)VLJQLILFDQWO\

HQKDQFHGWKHJURZWKDQGLQYDVLYHQHVVRIFDQFHUFHOOV003

H[SUHVVLRQZDVGHWHFWHGLQWKHK\SRSKDU\QJHDOFDQFHUFHOOV

DQGH[RJHQRXV(*)HQKDQFHGWKHH[SUHVVLRQDQGDFWLYLW\RI

003DQG003)XUWKHUPRUHWKHH[SUHVVLRQRI(*)5

ZDVDVVRFLDWHGZLWKWXPRUSURJUHVVLRQDQGWKHSURJQRVLVRI

SDWLHQWVZLWKK\SRSKDU\QJHDOFDQFHU)XUWKHUUHVHDUFKSHU

WDLQLQJWRWKHHIIHFWRI(*)(*)5RQK\SRSKDU\Q[FDQFHULQ

DODUJHUVWXG\SRSXODWLRQFRXOGDLGLQWKHGLDJQRVLVDQGPDQ

(10)

-  - DJHPHQWRIK\SRSKDU\QJHDOFDQFHU

$FNQRZOHGJPHQWV

7KLVVWXG\ZDVVXSSRUWHGE\&&5%WKURXJKWKH³*55&´3URMHFW

RIWKH*\HRQJJLSURYLQFLDOJRYHUQPHQWDQGWKH1DWLRQDO5HVHDUFK

)RXQGDWLRQRI.RUHD 15) JUDQW 5$$$ 

References

1) *UHHQOHH57+LOO+DUPRQ0%0XUUD\77KXQ0&DQFHUVWD

WLVWLFV&$&DQFHU-&OLQ  

2) $UWHDJD&7DUJHWLQJ+(5(*)5DPROHFXODUDSSURDFKWR

FDQFHUWKHUDS\6HPLQ2QFRO 6XSSO 

3) %DVHOJD-7DUJHWLQJWKHHSLGHUPDOJURZWKIDFWRUUHFHSWRUD

FOLQLFDOUHDOLW\-&OLQ2QFRO 6XSSO 66

4) %RQQHU-$+DUDUL30*LUDOW-$]DUQLD16KLQ'0&RKHQ

5%HWDO5DGLRWKHUDS\SOXVFHWX[LPDEIRUVTXDPRXVFHOO

FDUFLQRPDRIWKHKHDGDQGQHFN1(QJO-0HG  



5) &DUSHQWHU*&RKHQ6(SLGHUPDOJURZWKIDFWRU$QQX5HY%LR

FKHP

6) *UDQGLV-57ZHDUG\'-(OHYDWHGOHYHOVRIWUDQVIRUPLQJJURZWK

IDFWRUDOSKDDQGHSLGHUPDOJURZWKIDFWRUUHFHSWRUPHVVHQJHU

51$DUHHDUO\PDUNHUVRIFDUFLQRJHQHVLVLQKHDGDQGQHFNFDQ

FHU&DQFHU5HV  

7) 0L\DJXFKL02ORIVVRQ-+HOOTXLVW+%([SUHVVLRQRIHSLGHU

PDOJURZWKIDFWRUUHFHSWRULQJORWWLFFDUFLQRPDDQGLWVUHODWLRQ

WRUHFXUUHQFHDIWHUUDGLRWKHUDS\&OLQ2WRODU\QJRO$OOLHG6FL

  

8) 5XELQ*UDQGLV-0HOKHP0)*RRGLQJ:('D\5+ROVW9$

:DJHQHU00HWDO/HYHOVRI7*)DOSKDDQG(*)5SURWHLQLQ

KHDGDQGQHFNVTXDPRXVFHOOFDUFLQRPDDQGSDWLHQWVXUYLYDO

-1DWO&DQFHU,QVW  

9) 2QR0.XZDQR00ROHFXODUPHFKDQLVPVRIHSLGHUPDOJURZWK

IDFWRUUHFHSWRU (*)5 DFWLYDWLRQDQGUHVSRQVHWRJH¿WLQLEDQG

RWKHU(*)5WDUJHWLQJGUXJV&OLQ&DQFHU5HV  



10) 'DYLHV5/*URVVH9$.XFKHUODSDWL5%RWKZHOO0*HQHWLFDQDO

\VLVRIHSLGHUPDOJURZWKIDFWRUDFWLRQDVVLJQPHQWRIKXPDQHSL

GHUPDOJURZWKIDFWRUUHFHSWRUJHQHWRFKURPRVRPH3URF

1DWO$FDG6FL86$  

11) /HPPRQ0$6FKOHVVLQJHU-5HJXODWLRQRIVLJQDOWUDQVGXFWLRQ

DQGVLJQDOGLYHUVLW\E\UHFHSWRUROLJRPHUL]DWLRQ7UHQGV%LR

FKHP6FL  

12) &RZOH\*6PLWK-$*XVWHUVRQ%+HQGOHU)2]DQQH%7KH

DPRXQWRI(*)UHFHSWRULVHOHYDWHGRQVTXDPRXVFHOOFDUFLQR

PD&DQFHU&HOOV

13) &RZOH\*36PLWK-$*XVWHUVRQ%$,QFUHDVHG(*)UHFHSWRUV

RQKXPDQVTXDPRXVFDUFLQRPDFHOOOLQHV%U-&DQFHU

 

14) *XVWHUVRQ%&RZOH\*0F,OKLQQH\-2]DQQH%)LVKHU&

5HHYHV%(YLGHQFHIRULQFUHDVHGHSLGHUPDOJURZWKIDFWRUUH

FHSWRUVLQKXPDQVDUFRPDV,QW-&DQFHU  

15) 5REHUW)(]HNLHO036SHQFHU6$0HUHGLWK5)%RQQHU-$

.KD]DHOL0%HWDO3KDVH,VWXG\RIDQWLHSLGHUPDOJURZWK

IDFWRUUHFHSWRUDQWLERG\FHWX[LPDELQFRPELQDWLRQZLWKUDGLD

WLRQWKHUDS\LQSDWLHQWVZLWKDGYDQFHGKHDGDQGQHFNFDQFHU

-&OLQ2QFRO

16) =LPPHUPDQQ0=RXKDLU$$]ULD'2]VDKLQ07KHHSLGHU

PDOJURZWKIDFWRUUHFHSWRU (*)5 LQKHDGDQGQHFNFDQFHULWV

UROHDQGWUHDWPHQWLPSOLFDWLRQV5DGLDW2QFRO

17) (WLHQQH0&3LYRW;)RUPHQWR-/%HQVDGRXQ5-)RUPHQWR

3'DVVRQYLOOH2HWDO$PXOWLIDFWRULDODSSURDFKLQFOXGLQJWX

PRXUDOHSLGHUPDOJURZWKIDFWRUUHFHSWRUSWK\PLG\ODWHV\Q

WKDVHDQGGLK\GURS\ULPLGLQHGHK\GURJHQDVHWRSUHGLFWWUHDWPHQW

RXWFRPHLQKHDGDQGQHFNFDQFHUSDWLHQWVUHFHLYLQJÀXRUR

XUDFLO%U-&DQFHU  

18) 3XWWL7&7R.)+VX+&&KDQ$7/DL*07VH*HWDO([

SUHVVLRQRIHSLGHUPDOJURZWKIDFWRUUHFHSWRULQKHDGDQGQHFN

FDQFHUVFRUUHODWHVZLWKFOLQLFDOSURJUHVVLRQDPXOWLFHQWUHLP

PXQRKLVWRFKHPLFDOVWXG\LQWKH$VLD3DFL¿FUHJLRQ+LVWRSD

WKRORJ\  

19) 6PLWK%'6PLWK*/&DUWHU''L*LRYDQQD03.DVRZLW].0

6DVDNL&7HWDO0ROHFXODUPDUNHUH[SUHVVLRQLQRUDODQGRUR

SKDU\QJHDOVTXDPRXVFHOOFDUFLQRPD$UFK2WRODU\QJRO+HDG

1HFN6XUJ  

20) .XVXNDZD-+DUDGD+6KLPD,6DVDJXUL<.DPH\DPD7

0RULPDWVX07KHVLJQL¿FDQFHRIHSLGHUPDOJURZWKIDFWRUUH

FHSWRUDQGPDWUL[PHWDOORSURWHLQDVHLQVTXDPRXVFHOOFDUFL

QRPDRIWKHRUDOFDYLW\(XU-&DQFHU%2UDO2QFRO%

 

21) .DMDQQH50LHWWLQHQ30HKOHP$/HLYRQHQ6.%LUUHU0

)RVFKL0HWDO(*)5UHJXODWHV003IXQFWLRQLQ¿EUREODVWV

WKURXJK0$3.DQG$3SDWKZD\V-&HOO3K\VLRO



참조

관련 문서

┃치료 거부 및 무리한 치료 요구에 대한 대처┃.. 하지만 회복 가능성이 없으며, 치료를 통해 얻을 수 있는 이익이 적다면 환자의 의사를 존중해 주는 것이 나을

_____ culture appears to be attractive (도시의) to the

【판결요지】[1] [다수의견] 동일인의 소유에 속하는 토지 및 그 지상 건물에 관하여 공동저 당권이 설정된 후 그 지상 건물이 철거되고 새로 건물이 신축된 경우에는

It considers the energy use of the different components that are involved in the distribution and viewing of video content: data centres and content delivery networks

After first field tests, we expect electric passenger drones or eVTOL aircraft (short for electric vertical take-off and landing) to start providing commercial mobility

1 John Owen, Justification by Faith Alone, in The Works of John Owen, ed. John Bolt, trans. Scott Clark, &#34;Do This and Live: Christ's Active Obedience as the

내과적, 외과적 질환으로 치료를 받고 있는 환자의 경우, 다양한 정신과적 증상을 가지고 있기 때문에 이에 대한 평 가 및 적절한 치료가 필요하게 된다. 스트레스

기존에 연구가 진행된 혈액의 일반타액단백질의 농도 분석을 통해 나타난 결과 정상인에 비해 당뇨 환자의 일반타액단백질의 농도가 높은 것으로 나타났었고, 이번 실험을